ResearcherSecond Affiliated Hospital of Nanchang UniversityNo recent work listed

Binghai Zhou

ORCID-verified (high confidence)As of 13 November 2026

Matched on ORCID iD 0000-0002-0678-6628; OpenAlex author ID A5102970894.

Their work

Counts cover pancreatic cancer work only: a researcher’s other papers, trials and grants are not in these records.

Pancreatic cancer papers: 1 (first author 0, last author 1)
Pancreatic cancer trials: 0
Pancreatic cancer grants: 0
Collaborators: 1

Papers, trials and grants by year

2023: 1 paper

Papers 1

Disulfiram combined with chemoimmunotherapy potentiates pancreatic cancer treatment efficacy through the activation of cGAS-STING signaling pathway via suppres… Last author PMID 37293156 ↗

Closest collaborators

The 1 strongest of 1 ranked by shared papers, trials and grants, with recent and small-team work weighing most.

Shenan Huang · 1 shared paper, 2023
- Paper Disulfiram combined with chemoimmunotherapy potentiates pancreatic cancer treatment efficacy through the activation of … PMID 37293156 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.